Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

Singapore IPOs Tikams for 2018

2018 is a year to be forgotten for IPOs on the Singapore Exchange. SGX "failed" to attract any significant listings and most of the listings are currently underwater as shown by the table below.

(Source: Shareinvestor.com)

Mr. IPO has been reporting his IPO tikams (performances) since 2012. You can search for the prior posts here.  How did he perform in 2018?

Contrary to even my own expectations, 2018 turned out to be the best year i ever had because of a few significant "bets".

Majority of the gains came in the first half of 2018 and significantly from the RTO of Memories Group, which i took a significant placement shares , so technically it is not an IPO but I have classified it in the IPO category. The top 3 gains are as follows:
  1. Memories Group $ 19,471
  2. Asian Healthcare $  8,371
  3. SLB Development $ 3,366
While i have fared well in the IPO tikams, my personal portfolio suffered a big loss when i wrote down Hyflux Perps to 10% of its par value. At this juncture, I am not even sure if i can recover the written down value and i will blog about them in a separate post on  my passive income pursuit.

I think 2019 will continue to be challenging for the Singapore IPO market with SGX struggling to attract companies to list here. The market should continue to stay volatile in the first half and beyond that, it will be challenging to predict how the markets will perform. 

That is all from me for now. I take the opportunity to wish all readers good health, happiness and a wonderful 2018!  

Comments